UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000013338
Receipt No. R000015568
Official scientific title of the study Accuracy of subcutaneous continuous glucose monitor during perioperative period
Date of disclosure of the study information 2014/03/06
Last modified on 2016/04/08 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Accuracy of subcutaneous continuous glucose monitor during perioperative period
Title of the study (Brief title) Accuracy of subcutaneous continuous glucose monitor
Region
Japan

Condition
Condition Hepatocellular carcinoma, Pancreas tumor, Esophageal cancer
Classification by specialty
Hepato-biliary-pancreatic surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Aim of this study is examined the accuracy of a subcutaneous continuous glucose monitor during perioperative period.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Difference between glucose measured by subcutaneous continuous glucose monitor and glucose measured by artificial pancreas.
Key secondary outcomes

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Device,equipment
Interventions/Control_1 Subcutaneous continuous glucose monitor
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
85 years-old >=
Gender Male and Female
Key inclusion criteria Schedule operated patient of liver, pancreas and esophagus
Key exclusion criteria Patients who was not used an artificial pancreas for perioperative glucose control
Target sample size 15

Research contact person
Name of lead principal investigator Kazuhiro Hanazaki
Organization Kochi Medical School
Division name Surgery
Address Kohasu, Oko-cho, Nankoku, Kochi, Japan
TEL 088-880-2370
Email hanazaki@kochi-u.ac.jp

Public contact
Name of contact person Tomoaki Yatabe
Organization Kochi Medical School
Division name Anesthesiology
Address Kohasu, Oko-cho, Nankoku, Kochi, Japan
TEL 088-880-2471
Homepage URL
Email yatabe@kochi-u.ac.jp

Sponsor
Institute Department of Surgery, Kochi Medical School
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization Department of Surgery, Kochi Medical School
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 03 Month 06 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 02 Month 28 Day
Anticipated trial start date
2014 Year 03 Month 08 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results http://www.ncbi.nlm.nih.gov/pubmed/26721825
Results
Other related information

Management information
Registered date
2014 Year 03 Month 05 Day
Last modified on
2016 Year 04 Month 08 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-bin/ctr_e/ctr_view.cgi?recptno=R000015568